IMD PANEL QUANTITATIVE BLOOD Test
Test Name: IMD PANEL QUANTITATIVE BLOOD Test
Components: Amino Acids, Acylcarnitines, Adenosine, 2′-deoxyadenosine, Molar Ratios
Price: 940.0 AED
Sample Condition: 1 drop of heel prick blood each on 3 spots of filter paper available from LPL. Ship refrigerated or frozen. Clinical details and drug history must accompany sample.
Report Delivery: Sample Mon / Wed / Fri by 9 am; Report Next day
Method: Tandem Mass Spectrometry
Test Type: Inborn errors of metabolism
Doctor: Pediatrician
Test Department: Genetic
Pre Test Information: Clinical details and drug history must accompany sample.
Test Details
The IMD panel quantitative blood test is a diagnostic test used to measure the levels of certain substances or markers in the blood. IMD stands for inborn errors of metabolism, which are genetic disorders that affect the body’s ability to process certain substances.
This test is specifically designed to detect and monitor the levels of amino acids, organic acids, and acylcarnitines in the blood. These substances are important for various metabolic processes in the body.
The IMD panel quantitative blood test is typically ordered for individuals who are suspected to have a metabolic disorder or for those who have a family history of such disorders. It can help healthcare providers identify and diagnose specific metabolic disorders, such as phenylketonuria, maple syrup urine disease, or organic acidemias.
During the test, a blood sample is taken from the individual and sent to a laboratory for analysis. The laboratory technicians will measure the levels of amino acids, organic acids, and acylcarnitines in the blood. The results are then compared to established reference ranges to determine if there are any abnormalities.
The IMD panel quantitative blood test is an important tool in the diagnosis and management of metabolic disorders. It can help healthcare providers develop an appropriate treatment plan and monitor the effectiveness of interventions. However, it is important to note that this test is just one piece of the puzzle and should be used in conjunction with other clinical evaluations and tests to make a definitive diagnosis.
Test Name | IMD PANEL QUANTITATIVE BLOOD Test |
---|---|
Components | *Amino Acids*Acylcarnitines*Adenosine *2??-deoxyadenosine*Molar Ratios |
Price | 940.0 AED |
Sample Condition | 1 drop of heel prick blood each on 3 spots of filter paper available from LPL. Ship refrigerated or frozen. Clinical details and drug history must accompany sample. |
Report Delivery | Sample Mon / Wed / Fri by 9 am; Report Next day |
Method | Tandem Mass Spectrometry |
Test type | Inborn errors of metabolism |
Doctor | Pediatrician |
Test Department: | GENETIC |
Pre Test Information | Clinical details and drug history must accompany sample. |
Test Details | The IMD panel quantitative blood test is a diagnostic test used to measure the levels of certain substances or markers in the blood. IMD stands for inborn errors of metabolism, which are genetic disorders that affect the body’s ability to process certain substances. This test is specifically designed to detect and monitor the levels of amino acids, organic acids, and acylcarnitines in the blood. These substances are important for various metabolic processes in the body. The IMD panel quantitative blood test is typically ordered for individuals who are suspected to have a metabolic disorder or for those who have a family history of such disorders. It can help healthcare providers identify and diagnose specific metabolic disorders, such as phenylketonuria, maple syrup urine disease, or organic acidemias. During the test, a blood sample is taken from the individual and sent to a laboratory for analysis. The laboratory technicians will measure the levels of amino acids, organic acids, and acylcarnitines in the blood. The results are then compared to established reference ranges to determine if there are any abnormalities. The IMD panel quantitative blood test is an important tool in the diagnosis and management of metabolic disorders. It can help healthcare providers develop an appropriate treatment plan and monitor the effectiveness of interventions. However, it is important to note that this test is just one piece of the puzzle and should be used in conjunction with other clinical evaluations and tests to make a definitive diagnosis. |